A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...

Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without ...

New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...

AbClick leverages affinity peptide-assisted linkers for precise antibody-drug conjugation. To expedite ADC therapeutic ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...